Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
Author:
Affiliation:
1. Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Link
http://academic.oup.com/clinchem/article-pdf/51/5/904/32683449/clinchem0904.pdf
Reference24 articles.
1. Mahley RW, Rall S. Type III hyperlipoproteinemia (dysbetalipoproteinaemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver A Beaudet W Sly S Valle D eds. The metabolic and molecular bases of inherited disease1995:1953-1980 McGraw-Hill New York. .
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science1988;240:622-630.
3. Mahley RW, Huang Y, Rall SC, Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res1999;40:1933-1949.
4. Blom DJ, Byrnes P, Jones S, Marais AD. Dysbetalipoproteinaemia—clinical and pathophysiological features. S Afr Med J2002;92:892-897.
5. Civeira F, Pocovi M, Cenarro A, Casao E, Vilella E, Joven J, et al. Apo E variants in patients with type III hyperlipoproteinemia. Atherosclerosis1996;127:273-282.
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications;Diabetes Therapy;2024-07-30
2. Evaluation of biochemical algorithms to screen dysbetalipoproteinemia in ε2ε2 and rare APOE variants carriers;Clinical Chemistry and Laboratory Medicine (CCLM);2024-07-29
3. Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa;Journal of Neuroendocrinology;2024-06-10
4. Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic Criteria;The Journal of Clinical Endocrinology & Metabolism;2024-04-16
5. Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial;Journal of Clinical Lipidology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3